Report generated for: Observation
Server: http://localhost:8085/fhir
Total Unique Values Found: 276
==================================================
ALT (Elevated)
AST (Elevated)
Abuse Status [OMAHA]
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
Albumin
Albumin [Mass/volume] in Serum or Plasma
Alkaline Phosphatase
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
American house dust mite IgE Ab in Serum
Anion Gap
Appearance of Urine
Are you covered by health insurance or some other kind of health care plan [PhenX]
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
Bilirubin.total [Mass/volume] in Serum or Plasma
Bilirubin.total [Mass/volume] in Urine by Test strip
Bilirubin.total [Presence] in Urine by Test strip
Blood Pressure
Body Height
Body Mass Index
Body Weight
Body mass index (BMI) [Percentile] Per age and gender
Body temperature
Calcium
Calcium [Mass/volume] in Serum or Plasma
Carbon Dioxide
Carbon dioxide, total [Moles/volume] in Serum or Plasma
Cat dander IgE Ab in Serum
Cause of Death [US Standard Certificate of Death]
Chloride
Chloride [Moles/volume] in Serum or Plasma
Cladosporium herbarum IgE Ab in Serum
Clarity of Urine
Codfish IgE Ab in Serum
Color of Urine
Common Ragweed IgE Ab in Serum
Cow milk IgE Ab in Serum
Creatinine
Creatinine [Mass/volume] in Serum or Plasma
DXA [T-score] Bone density
Distant metastases.clinical [Class] Cancer
Egg white IgE Ab in Serum
Electrocardiographic procedure
Erythrocyte distribution width [Entitic volume] by Automated count
Erythrocyte distribution width [Ratio] by Automated count
Erythrocytes [#/volume] in Blood by Automated count
Estimated Glomerular Filtration Rate
Estrogen receptor Ag [Presence] in Breast cancer specimen by Immune stain
Estrogen+Progesterone receptor Ag [Presence] in Tissue by Immune stain
FEV1/FVC
Ferritin [Mass/volume] in Serum or Plasma
Functional capacity NYHA
Globulin
Globulin [Mass/volume] in Serum by calculation
Glomerular filtration rate/1.73 sq M.predicted
Glucose
Glucose [Mass/volume] in Serum or Plasma
Glucose [Mass/volume] in Urine by Test strip
Glucose [Presence] in Urine by Test strip
HER2 [Presence] in Breast cancer specimen by FISH
HER2 [Presence] in Breast cancer specimen by Immune stain
HIV status
Head Occipital-frontal circumference
Heart rate
Hematocrit
Hematocrit [Volume Fraction] of Blood
Hematocrit [Volume Fraction] of Blood by Automated count
Hemoglobin
Hemoglobin A1c/Hemoglobin.total in Blood
Hemoglobin [Mass/volume] in Blood
Hemoglobin [Presence] in Urine by Test strip
Hemoglobin.gastrointestinal [Presence] in Stool by Immunologic method
High Density Lipoprotein Cholesterol
History of Hospitalizations+Outpatient visits
Honey bee IgE Ab in Serum
Housing status
Iron [Mass/volume] in Serum or Plasma
Iron binding capacity [Mass/volume] in Serum or Plasma
Iron saturation [Mass Fraction] in Serum or Plasma
Ketones [Mass/volume] in Urine by Test strip
Ketones [Presence] in Urine by Test strip
Latex IgE Ab in Serum
Left ventricular Ejection fraction
Leukocyte esterase [Presence] in Urine by Test strip
Leukocytes [#/volume] in Blood by Automated count
Low Density Lipoprotein Cholesterol
Lymph nodes with macrometastases [#] in Cancer specimen by Light microscopy
Lymph nodes with micrometastases [#] in Cancer specimen by Light microscopy
MCH [Entitic mass] by Automated count
MCHC [Mass/volume] by Automated count
MCV
MCV [Entitic volume] by Automated count
Magnesium [Mass/volume] in Serum or Plasma
Microalbumin Creatinine Ratio
NT-proBNP
Nitrite [Presence] in Urine by Test strip
Objective assessment of cardiovascular disease NYHA
Odor of Urine
Oxygen saturation in Arterial blood
Pain severity - 0-10 verbal numeric rating [Score] - Reported
Peanut IgE Ab in Serum
Physical findings of Abdomen by Palpation
Physical findings of Prostate
Platelet Count
Platelet distribution width [Entitic volume] in Blood by Automated count
Platelet mean volume [Entitic volume] in Blood by Automated count
Platelets [#/volume] in Blood by Automated count
Polyp size greatest dimension by CAP cancer protocols
Potassium
Potassium [Moles/volume] in Serum or Plasma
Primary tumor.clinical [Class] Cancer
Progesterone receptor Ag [Presence] in Breast cancer specimen by Immune stain
Prostate specific Ag [Mass/volume] in Serum or Plasma
Protein
Protein [Mass/volume] in Serum or Plasma
Protein [Mass/volume] in Urine by Test strip
Protein [Presence] in Urine by Test strip
RBC Auto (Bld) [#/Vol]
RBC Distribution Width
RDW - Erythrocyte distribution width Auto (RBC) [Entitic vol]
Red Blood Cell
Regional lymph nodes.clinical [Class] Cancer
Respiratory rate
Response to cancer treatment
Sexual orientation
Shrimp IgE Ab in Serum
Site of distant metastasis in Breast tumor
Size.maximum dimension in Tumor
Sodium
Sodium [Moles/volume] in Serum or Plasma
Soybean IgE Ab in Serum
Specific gravity of Urine by Test strip
Stage group.clinical Cancer
Symptom
The ABCG2 gene exhibits a variation of 'Association' clinical significance. The variation at index rs2231137_FS1 is associated with an increased risk of: Cardiovascular Issues and Ischemic Stroke.
The ABCG2 gene exhibits a variation of 'Association' clinical significance. The variation at index rs2231137_FS2 is associated with an increased risk of: Cardiovascular Issues and Ischemic Stroke.
The ADD1 gene exhibits a variation of 'Risk Factor' clinical significance. The variation at index rs4961_FS1 is associated with an increased risk of: Cardiovascular Issues, High LDL, Hemorrhagic Stroke, Hypertension and High Blood Pressure.
The ADD1 gene exhibits a variation of 'Risk Factor' clinical significance. The variation at index rs4961_FS2 is associated with an increased risk of: Cardiovascular Issues, High LDL, Hemorrhagic Stroke, Hypertension and High Blood Pressure.
The ADRA2B gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs2229169_FS1 is associated with an increased risk of: Cardiovascular Issues and Ischemic Stroke.
The ADRA2B gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs2229169_FS2 is associated with an increased risk of: Cardiovascular Issues and Ischemic Stroke.
The ADRB2 gene exhibits a variation of 'Drug Response' clinical significance. The variation at index rs1800888_FS1 is associated with an increased risk of: Ischemic Stroke.
The ADRB2 gene exhibits a variation of 'Drug Response' clinical significance. The variation at index rs1800888_FS2 is associated with an increased risk of: Ischemic Stroke.
The ADRB3 gene exhibits a variation of 'Risk Factor' clinical significance. The variation at index rs4994_FS1 is associated with an increased risk of: Cardiovascular Issues and Ischemic Stroke.
The ADRB3 gene exhibits a variation of 'Risk Factor' clinical significance. The variation at index rs4994_FS2 is associated with an increased risk of: Cardiovascular Issues and Ischemic Stroke.
The AGT gene exhibits a variation of 'Risk Factor' clinical significance. The variation at index rs699_FS1 is associated with an increased risk of: Ischemic Stroke, Pulmonary Hypertension and Cardiomyopathy.
The AGT gene exhibits a variation of 'Risk Factor' clinical significance. The variation at index rs699_FS2 is associated with an increased risk of: Ischemic Stroke, Pulmonary Hypertension and Cardiomyopathy.
The AGTR1 gene exhibits a variation of 'Risk Factor' clinical significance. The variation at index rs5186_FS1 is associated with an increased risk of: Ischemic Stroke, Cardiomyopathy, Hypertension, High Blood Pressure and Cardiac Arrest.
The AGTR1 gene exhibits a variation of 'Risk Factor' clinical significance. The variation at index rs5186_FS2 is associated with an increased risk of: Ischemic Stroke, Cardiomyopathy, Hypertension, High Blood Pressure and Cardiac Arrest.
The ALOX15 gene exhibits a variation of 'Benign' clinical significance. The variation at index rs34210653_FS1 is associated with an increased risk of: Ischemic Stroke.
The ALOX15 gene exhibits a variation of 'Benign' clinical significance. The variation at index rs34210653_FS2 is associated with an increased risk of: Ischemic Stroke.
The ALOX5AP gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs10507391_FS1 is associated with an increased risk of: Cardiovascular Issues and Ischemic Stroke.
The ALOX5AP gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs10507391_FS2 is associated with an increased risk of: Cardiovascular Issues and Ischemic Stroke.
The APOA5 gene exhibits a variation of 'Drug Response' clinical significance. The variation at index rs662799_FS1 is associated with an increased risk of: Cardiovascular Issues, Dsyslipidemia, Low HDL, Ischemic Stroke, Obesity and Heart Disease.
The APOA5 gene exhibits a variation of 'Drug Response' clinical significance. The variation at index rs662799_FS2 is associated with an increased risk of: Cardiovascular Issues, Dsyslipidemia, Low HDL, Ischemic Stroke, Obesity and Heart Disease.
The APOC1 gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs4420638_FS1 is associated with an increased risk of: Cardiovascular Issues, Aortic Aneurysm, Dsyslipidemia, High LDL and Low HDL.
The APOC1 gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs4420638_FS2 is associated with an increased risk of: Cardiovascular Issues, Aortic Aneurysm, Dsyslipidemia, High LDL and Low HDL.
The APOE gene exhibits a variation of 'Pathogenic' clinical significance. The variation at index rs429358_FS1 is associated with an increased risk of: Cardiovascular Issues, Arterial Occlusive Disease, Dsyslipidemia, High LDL and Aortic Aneurysm.
The APOE gene exhibits a variation of 'Pathogenic' clinical significance. The variation at index rs429358_FS2 is associated with an increased risk of: Cardiovascular Issues, Arterial Occlusive Disease, Dsyslipidemia, High LDL and Aortic Aneurysm.
The BOLL gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs700651_FS1 is associated with an increased risk of: Aneurysm.
The BOLL gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs700651_FS2 is associated with an increased risk of: Aneurysm.
The CCL2 gene exhibits a variation of 'Pathogenic' clinical significance. The variation at index rs1024611_FS1 is associated with an increased risk of: Ischemic Stroke and Pulmonary Hypertension.
The CCL2 gene exhibits a variation of 'Pathogenic' clinical significance. The variation at index rs1024611_FS2 is associated with an increased risk of: Ischemic Stroke and Pulmonary Hypertension.
The CDKN2B, CDKN2B-AS1 gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs3217992_FS1 is associated with an increased risk of: Ischemic Stroke.
The CDKN2B, CDKN2B-AS1 gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs3217992_FS2 is associated with an increased risk of: Ischemic Stroke.
The CDKN2B-AS1 gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs10757272_FS1 is associated with an increased risk of: Aneurysm.
The CDKN2B-AS1 gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs10757272_FS2 is associated with an increased risk of: Aneurysm.
The CDKN2B-AS1 gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs10757274_FS1 is associated with an increased risk of: Cardiovascular Issues, Ischemic Stroke, Heart Disease, Aneurysm and Aortic Aneurysm.
The CDKN2B-AS1 gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs10757274_FS2 is associated with an increased risk of: Cardiovascular Issues, Ischemic Stroke, Heart Disease, Aneurysm and Aortic Aneurysm.
The CDKN2B-AS1 gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs1333040_FS1 is associated with an increased risk of: Ischemic Stroke and Aneurysm.
The CDKN2B-AS1 gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs1333040_FS2 is associated with an increased risk of: Ischemic Stroke and Aneurysm.
The CDKN2B-AS1 gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs2383206_FS1 is associated with an increased risk of: Cardiovascular Issues, Heart Disease and Ischemic Stroke.
The CDKN2B-AS1 gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs2383206_FS2 is associated with an increased risk of: Cardiovascular Issues, Heart Disease and Ischemic Stroke.
The CDKN2B-AS1 gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs2383207_FS1 is associated with an increased risk of: Cardiovascular Issues, Aneurysm, Aortic Aneurysm and Ischemic Stroke.
The CDKN2B-AS1 gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs2383207_FS2 is associated with an increased risk of: Cardiovascular Issues, Aneurysm, Aortic Aneurysm and Ischemic Stroke.
The CRP gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs3093059_FS1 is associated with an increased risk of: Cardiovascular Issues, Hemorrhagic Stroke and Ischemic Stroke.
The CRP gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs3093059_FS2 is associated with an increased risk of: Cardiovascular Issues, Hemorrhagic Stroke and Ischemic Stroke.
The CYP2C19 gene exhibits a variation of 'Drug Response' clinical significance. The variation at index rs4244285_FS1 is associated with an increased risk of: Thrombosis and Cardiovascular Issues.
The CYP2C19 gene exhibits a variation of 'Drug Response' clinical significance. The variation at index rs4244285_FS2 is associated with an increased risk of: Thrombosis and Cardiovascular Issues.
The DAB2IP gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs7025486_FS1 is associated with an increased risk of: Aortic Aneurysm, Aneurysm, Pulmonary Hypertension and Ischemic Stroke.
The DAB2IP gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs7025486_FS2 is associated with an increased risk of: Aortic Aneurysm, Aneurysm, Pulmonary Hypertension and Ischemic Stroke.
The F12, SLC34A1 gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs383830_FS1 is associated with an increased risk of: Cardiovascular Issues, Heart Disease and Thrombosis.
The F12, SLC34A1 gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs383830_FS2 is associated with an increased risk of: Cardiovascular Issues, Heart Disease and Thrombosis.
The F2 gene exhibits a variation of 'Pathogenic' clinical significance. The variation at index rs1799963_FS1 is associated with an increased risk of: Pulmonary Hypertension, Cardiovascular Issues, Ischemic Stroke, Thrombosis and Arterial Occlusive Disease.
The F2 gene exhibits a variation of 'Pathogenic' clinical significance. The variation at index rs1799963_FS2 is associated with an increased risk of: Pulmonary Hypertension, Cardiovascular Issues, Ischemic Stroke, Thrombosis and Arterial Occlusive Disease.
The F5 gene exhibits a variation of 'Pathogenic' clinical significance. The variation at index rs6025_FS1 is associated with an increased risk of: Cardiovascular Issues, Arterial Occlusive Disease, Thrombosis, Pulmonary Hypertension, Ischemic Stroke and Stroke.
The F5 gene exhibits a variation of 'Pathogenic' clinical significance. The variation at index rs6025_FS2 is associated with an increased risk of: Cardiovascular Issues, Arterial Occlusive Disease, Thrombosis, Pulmonary Hypertension, Ischemic Stroke and Stroke.
The FBN1 gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs2118181_FS1 is associated with an increased risk of: Aortic Aneurysm.
The FBN1 gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs2118181_FS2 is associated with an increased risk of: Aortic Aneurysm.
The FTO gene exhibits a variation of 'Risk Factor' clinical significance. The variation at index rs1421085_FS1 is associated with an increased risk of: Aortic Aneurysm and Insulin Resistance.
The FTO gene exhibits a variation of 'Risk Factor' clinical significance. The variation at index rs1421085_FS2 is associated with an increased risk of: Aortic Aneurysm and Insulin Resistance.
The GCH1 gene exhibits a variation of 'Benign' clinical significance. The variation at index rs841_FS1 is associated with an increased risk of: Ischemic Stroke.
The GCH1 gene exhibits a variation of 'Benign' clinical significance. The variation at index rs841_FS2 is associated with an increased risk of: Ischemic Stroke.
The HABP2 gene exhibits a variation of 'Benign' clinical significance. The variation at index rs7080536_FS1 is associated with an increased risk of: Thrombosis.
The HABP2 gene exhibits a variation of 'Benign' clinical significance. The variation at index rs7080536_FS2 is associated with an increased risk of: Thrombosis.
The HFE gene exhibits a variation of 'Pathogenic' clinical significance. The variation at index rs1799945_FS1 is associated with an increased risk of: Cardiovascular Issues, Thrombosis, Insulin Resistance, Ischemic Stroke, Pulmonary Hypertension and Hemorrhagic Stroke.
The HFE gene exhibits a variation of 'Pathogenic' clinical significance. The variation at index rs1799945_FS2 is associated with an increased risk of: Cardiovascular Issues, Thrombosis, Insulin Resistance, Ischemic Stroke, Pulmonary Hypertension and Hemorrhagic Stroke.
The IL18 gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs187238_FS1 is associated with an increased risk of: Ischemic Stroke.
The IL18 gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs187238_FS2 is associated with an increased risk of: Ischemic Stroke.
The IL6 gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs1800796_FS1 is associated with an increased risk of: Cardiovascular Issues, Aortic Aneurysm, Thrombosis and Ischemic Stroke.
The IL6 gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs1800796_FS2 is associated with an increased risk of: Cardiovascular Issues, Aortic Aneurysm, Thrombosis and Ischemic Stroke.
The ITGB3 gene exhibits a variation of 'Benign' clinical significance. The variation at index rs5918_FS1 is associated with an increased risk of: Ischemic Stroke, Arterial Occlusive Disease and Thrombosis.
The ITGB3 gene exhibits a variation of 'Benign' clinical significance. The variation at index rs5918_FS2 is associated with an increased risk of: Ischemic Stroke, Arterial Occlusive Disease and Thrombosis.
The LOC100287329, LTA gene exhibits a variation of 'Risk Factor' clinical significance. The variation at index rs1041981_FS1 is associated with an increased risk of: Ischemic Stroke.
The LOC100287329, LTA gene exhibits a variation of 'Risk Factor' clinical significance. The variation at index rs1041981_FS2 is associated with an increased risk of: Ischemic Stroke.
The LOC729065 gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs2200733_FS1 is associated with an increased risk of: Ischemic Stroke and Stroke.
The LOC729065 gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs2200733_FS2 is associated with an increased risk of: Ischemic Stroke and Stroke.
The LPA gene exhibits a variation of 'Drug Response' clinical significance. The variation at index rs10455872_FS1 is associated with an increased risk of: Ischemic Stroke, Cardiovascular Issues, Heart Valve Disease, Mitral valve issues and High LDL.
The LPA gene exhibits a variation of 'Drug Response' clinical significance. The variation at index rs10455872_FS2 is associated with an increased risk of: Ischemic Stroke, Cardiovascular Issues, Heart Valve Disease, Mitral valve issues and High LDL.
The LPA gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs10033464_FS1 is associated with an increased risk of: Ischemic Stroke.
The LPA gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs10033464_FS2 is associated with an increased risk of: Ischemic Stroke.
The LPL gene exhibits a variation of 'Pathogenic' clinical significance. The variation at index rs268_FS1 is associated with an increased risk of: Ischemic Stroke and Low HDL.
The LPL gene exhibits a variation of 'Pathogenic' clinical significance. The variation at index rs268_FS2 is associated with an increased risk of: Ischemic Stroke and Low HDL.
The MYH15 gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs3900940_FS1 is associated with an increased risk of: Cardiovascular Issues and Ischemic Stroke.
The MYH15 gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs3900940_FS2 is associated with an increased risk of: Cardiovascular Issues and Ischemic Stroke.
The PALLD gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs7439293_FS1 is associated with an increased risk of: Cardiovascular Issues and Ischemic Stroke.
The PALLD gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs7439293_FS2 is associated with an increased risk of: Cardiovascular Issues and Ischemic Stroke.
The PDE4D gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs966221_FS1 is associated with an increased risk of: Ischemic Stroke.
The PDE4D gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs966221_FS2 is associated with an increased risk of: Ischemic Stroke.
The PON1 gene exhibits a variation of 'Risk Factor' clinical significance. The variation at index rs662_FS1 is associated with an increased risk of: Cardiovascular Issues, Mitral valve issues, Dsyslipidemia, Insulin Resistance, Low HDL and Ischemic Stroke.
The PON1 gene exhibits a variation of 'Risk Factor' clinical significance. The variation at index rs662_FS2 is associated with an increased risk of: Cardiovascular Issues, Mitral valve issues, Dsyslipidemia, Insulin Resistance, Low HDL and Ischemic Stroke.
The PON1 gene exhibits a variation of 'Risk Factor' clinical significance. The variation at index rs854560_FS1 is associated with an increased risk of: Cardiovascular Issues, Insulin Resistance, Low HDL, Ischemic Stroke and Hypercholesterolemia.
The PON1 gene exhibits a variation of 'Risk Factor' clinical significance. The variation at index rs854560_FS2 is associated with an increased risk of: Cardiovascular Issues, Insulin Resistance, Low HDL, Ischemic Stroke and Hypercholesterolemia.
The PRKCH gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs3783799_FS1 is associated with an increased risk of: Stroke.
The PRKCH gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs3783799_FS2 is associated with an increased risk of: Stroke.
The PSMA6 gene exhibits a variation of 'Risk Factor' clinical significance. The variation at index rs1048990_FS1 is associated with an increased risk of: Ischemic Stroke.
The PSMA6 gene exhibits a variation of 'Risk Factor' clinical significance. The variation at index rs1048990_FS2 is associated with an increased risk of: Ischemic Stroke.
The PSRC1 gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs599839_FS1 is associated with an increased risk of: Cardiovascular Issues, Dsyslipidemia, Heart Disease, High LDL and Aortic Aneurysm.
The PSRC1 gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs599839_FS2 is associated with an increased risk of: Cardiovascular Issues, Dsyslipidemia, Heart Disease, High LDL and Aortic Aneurysm.
The PTGS1 gene exhibits a variation of 'Drug Response' clinical significance. The variation at index rs10306114_FS1 is associated with an increased risk of: Cardiovascular Issues and Ischemic Stroke.
The PTGS1 gene exhibits a variation of 'Drug Response' clinical significance. The variation at index rs10306114_FS2 is associated with an increased risk of: Cardiovascular Issues and Ischemic Stroke.
The PTGS1 gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs3842787_FS1 is associated with an increased risk of: Cardiovascular Issues and Ischemic Stroke.
The PTGS1 gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs3842787_FS2 is associated with an increased risk of: Cardiovascular Issues and Ischemic Stroke.
The RP1 gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs9298506_FS1 is associated with an increased risk of: Aneurysm.
The RP1 gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs9298506_FS2 is associated with an increased risk of: Aneurysm.
The SELE gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs5361_FS1 is associated with an increased risk of: Ischemic Stroke, Arterial Occlusive Disease and Thrombosis.
The SELE gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs5361_FS2 is associated with an increased risk of: Ischemic Stroke, Arterial Occlusive Disease and Thrombosis.
The SERPINI1 gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs6797312_FS1 is associated with an increased risk of: Ischemic Stroke, Stroke and Low HDL.
The SERPINI1 gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs6797312_FS2 is associated with an increased risk of: Ischemic Stroke, Stroke and Low HDL.
The STARD13 gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs9315204_FS1 is associated with an increased risk of: Aneurysm.
The STARD13 gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs9315204_FS2 is associated with an increased risk of: Aneurysm.
The TLR4 gene exhibits a variation of 'Benign' clinical significance. The variation at index rs4986790_FS1 is associated with an increased risk of: Cardiovascular Issues, Insulin Resistance, Low HDL, Ischemic Stroke, Dilated Cardiomyopathy, Pulmonary Hypertension and Ischemic Stroke.
The TLR4 gene exhibits a variation of 'Benign' clinical significance. The variation at index rs4986790_FS2 is associated with an increased risk of: Cardiovascular Issues, Insulin Resistance, Low HDL, Ischemic Stroke, Dilated Cardiomyopathy, Pulmonary Hypertension and Ischemic Stroke.
The Unlisted gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs10757278_FS1 is associated with an increased risk of: Cardiovascular Issues, Heart Disease, Aortic Aneurysm and Ischemic Stroke.
The Unlisted gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs10757278_FS2 is associated with an increased risk of: Cardiovascular Issues, Heart Disease, Aortic Aneurysm and Ischemic Stroke.
The Unlisted gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs10958409_FS1 is associated with an increased risk of: Aneurysm.
The Unlisted gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs10958409_FS2 is associated with an increased risk of: Aneurysm.
The Unlisted gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs1333048_FS1 is associated with an increased risk of: Cardiovascular Issues, Aortic Aneurysm, Ischemic Stroke and Heart Disease.
The Unlisted gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs1333048_FS2 is associated with an increased risk of: Cardiovascular Issues, Aortic Aneurysm, Ischemic Stroke and Heart Disease.
The Unlisted gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs1746048_FS1 is associated with an increased risk of: Cardiovascular Issues and Ischemic Stroke.
The Unlisted gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs1746048_FS2 is associated with an increased risk of: Cardiovascular Issues and Ischemic Stroke.
The Unlisted gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs2943634_FS1 is associated with an increased risk of: Cardiovascular Issues, Heart Disease, Low HDL, Insulin Resistance and Ischemic Stroke.
The Unlisted gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs2943634_FS2 is associated with an increased risk of: Cardiovascular Issues, Heart Disease, Low HDL, Insulin Resistance and Ischemic Stroke.
The Unlisted gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs501120_FS1 is associated with an increased risk of: Cardiovascular Issues, Ischemic Stroke and Heart Disease.
The Unlisted gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs501120_FS2 is associated with an increased risk of: Cardiovascular Issues, Ischemic Stroke and Heart Disease.
The ZPR1 gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs964184_FS1 is associated with an increased risk of: Ischemic Stroke, Hemorrhagic Stroke, Dsyslipidemia and Low HDL.
The ZPR1 gene exhibits a variation of 'Uncertain' clinical significance. The variation at index rs964184_FS2 is associated with an increased risk of: Ischemic Stroke, Hemorrhagic Stroke, Dsyslipidemia and Low HDL.
Thyrotropin [Units/volume] in Serum or Plasma
Thyroxine (T4) free [Mass/volume] in Serum or Plasma
Tobacco smoking status NHIS
Total Bilirubin (Elevated)
Total Cholesterol
Total score [MMSE]
Treatment status Cancer
Triglycerides
Troponin I.cardiac [Mass/volume] in Serum or Plasma by High sensitivity method
Tumor marker Cancer
US Guidance for biopsy of Prostate
Urea Nitrogen
Urea nitrogen [Mass/volume] in Serum or Plasma
WBC Auto (Bld) [#/Vol]
Walnut IgE Ab in Serum
Weight difference [Mass difference] --pre dialysis - post dialysis
Weight-for-length Per age and sex
Wheat IgE Ab in Serum
White Blood Cell (Elevated)
White oak IgE Ab in Serum
pH of Urine by Test strip
